Gillette India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Gillette India Ltd · Financial Result · 13 Nov 2026, 6:31 pm
Gillette India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 84,610 (+4.4% YoY | +8.1% QoQ) ■ EBITDA: 22,736 (+9.4% YoY | -0.2% QoQ) ■ EBITDA Margin (%): 26.9 (+125 bps YoY | -222 bps QoQ) ■ PAT: 15,910 (+10.8% YoY | -0.2% QoQ) ■ EPS (INR): 48.8 (+10.8% YoY | -0.2% QoQ) Gillette India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) Segmental Performance Grooming ■ Revenue: 67,900 (+2.0% YoY | +8.0% QoQ) ■ EBIT: 19,243 (+18.5% YoY | +10.9% QoQ) ■ EBIT Margin (%): 28.3 (+396 bps YoY | +75 bps QoQ) Oral Care ■ Revenue: 16,710 (+15.3% YoY | +8.2% QoQ) ■ EBIT: 1,748 (-31.8% YoY | -53.6% QoQ) ■ EBIT Margin (%): 10.5 (-723 bps YoY | -1397 bps QoQ)
Original exchange filing (PDF)
More announcements from Gillette India Ltd
- Gillette India Limited has informed the Exchange regarding the update on Special Window for transfer and dematerialization of physical securities. · 18 Nov 2026
- Gillette India Limited has informed the Exchange about the disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 · 17 Nov 2026
- The Company has informed Exchange regarding press release on unaudited financial results for the quarter and half year ended September 30, 2026 · 13 Nov 2026
- Approval of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026 · 13 Nov 2026
- Gillette India Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 13 Nov 2026
- GILLETTE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 13 Nov 2026
- Gillette India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited Financial Results .... · 13 Nov 2026
